Qiagen NV


Market Cap$9.74B

Compare Qiagen NV

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Qiagen NVQiagen NV29.30%9%5.40.4
marketMarket Avg49.51.28%13%6.20.1
HealthcareHealthcare Avg31.91.26%18%7.50.9

Current Fair Value

7% upside

Undervalued by 7% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.74 Billion
Enterprise Value$10.21 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$1.44
Outstanding Shares228,000,000
Avg 30 Day Volume1,407,099


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio29.3
Price to Sales5.44
Price to Book Ratio2.72
Enterprise Value to Revenue5.22
Enterprise Value to EBIT23.39
Enterprise Value to Net Income30
Total Debt to Enterprise0.15
Debt to Equity0.4

Revenue Sources

No data

ESG Score

No data

About Qiagen NV

CEO: Thierry Bernard